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Electrostatic interactions between γ-Fe2O3 nanoparticles and CB[7]
Figure S 1: (A) TEM image of γ-Fe2O3 nanoparticles. (B) Infrared thermography images
and (C) temperature increase of γ-Fe2O3 nanoparticles dissolved in water or encapsulated in
HSH. (D) Hydrodynamic diameter and (E) zeta potential of bare and functionalized γ-Fe2O3
nanoparticles.
Superparamagnetic γ-Fe2O3 nanoparticles with an average diameter of 7 nm were ob-
tained as shown in the TEM image in Figure S1A. γ-Fe2O3 nanoparticles (0.1 wt%) dis-
persed either in water or HSH exhibited different thermal response to applied ~B (5 min) as
shown in Figure S1B, where a much more pronounced increase in temperature was observed
in HSH. This is likely due to the electrostatic interactions between CB[7] and the γ-Fe2O3
nanoparticles, which stabilize the nanoparticles in a well-dispersed form and enhance their
magnetic properties. Temperature increase under ~B in either water or HSH while varying
the concentration of superparamagnetic nanoparticles is presented in detail in Figure S1C,
where unstabilized nanoparticles in water show much less thermal response to the applied
magnetic field.
As shown by the solid lines in Figure S1D and E, hydrodynamic diameter Dh and zeta
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potential of the prepared bare γ-Fe2O3 nanoparticles are 29 nm (PD = 0.09) and -1 mV,
respectively. In order to examine the coordination bonding between γ-Fe2O3 nanoparticles
and the organic components in HSH, γ-Fe2O3 nanoparticles (10 mg) were added to an aque-
ous solution of CB[7] (1 mL, 23 mg, 20 mM), CAT-CS (1 mL, 20 mg, [CAT] = 20 mM)
or CAT⊂CB[7]-CS (1 mL, 43 mg, [CAT⊂CB[7]] = 20 mM), and the assembly process was
followed by DLS. As shown in Figure S1D, Dh of γ-Fe2O3 nanoparticles was increased to
35 nm, 81 nm and 173 nm upon complexation with CB[7], CAT-CS or CAT⊂CB[7]-CS,
respectively, inferring the assembly of these organic components on the peripheries of the
nanoparticles. γ-Fe2O3 nanoparticles show increased Dh upon addition of CAT-CS without
CB[7], likely on account of the interactions between CAT motifs and the nanoparticle sur-
face. While having similar molecular structures, CAT⊂CB[7]-CS displays more significant
influence on Dh of the nanoparticles compared to CAT-CS, suggesting stronger interactions
attributed to the presence of CB[7].
As shown in Figure S1E, zeta potential of γ-Fe2O3 nanoparticles was changed to -23 mV,
21 mV and 29 mV upon complexation with CB[7], CAT-CS or CAT⊂CB[7]-CS, respectively.
Assembly of CB[7] on the peripheries of the nanoparticles tunes their zeta potential to
negative due to the electronegative carbonyl portals of CB[7]. On the contrary, zeta potential
of the nanoparticles was changed to positive upon addition of CAT-CS and CAT⊂CB[7]-CS,
likely on account of the side-chain amine groups of CS. The positive zeta potential upon
addition of CAT⊂CB[7]-CS confirms the formation of coordination bonding between the
nanoparticles and CB[7] at the nanoparticles-polymer interface, thus shielding CB[7] and
exposing amine groups. Both size measurement and zeta potential analysis conform the
electrostatic interactions between γ-Fe2O3 nanoparticles and CB[7].
Cell study protocals
HSH was analyzed for cytotoxicity using HeLa cells, which were cultivated in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10 vol% fetal bovine serum and 1 vol%
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penicillin and streptomycin (complete growth medium) at 37 ◦C and 5% CO2 in a humidified
incubator. Cells were grown as monolayer and passaged upon approx. 80% confluence with
trypsin (0.25% with EDTA, 3 min). After adding complete growth medium to neutralise the
trypsin, cells were harvested from culture medium via centrifugation and the supernatant
was discarded. Cells were then resuspended in complete growth medium at a concentration
of 1.2 × 105 cells per ml in a polystyrene 12-well plate. Cells passages 5-8 were used for
cytotoxicity studies.
HSH was cut into discs (12.5 mm diameter, 5 mm height) and placed in complete growth
medium at 37 ◦C for 48 h. HeLa cells were seeded at 1.2 × 105 cells per ml in a polystyrene
12-well plate for 24 h. The cell culture medium was then discarded and replaced by the
medium which was used to soak the HSH. The well plate was placed in the incubator for
another 24 h. For MTT assay, cells were treated with MTT solution (5 mg/ml) for 4 h at
37 ◦C. Subsequently, the MTT solution was replaced by DMSO and the absorbance measured
at 490 nm. Cell viability was calculated as follows:
Cell viability =
[A]test − [A]medium
[A]control − [A]medium × 100% (1)
where [A]test is the mean absorbance of test sample, [A]medium is the mean absorbance of
culture medium, and [A]control is the mean absorbance of untreated sample.
The HSH exhibits high cell viability (98%) for HeLa cells, indicating potential biocom-
patibility.
In vivo cargo release
In vivo stability of HSH hydrogels is demonstrated using C57BL/6 mice obtained from Model
Animal Research Centre of Nanjing University (Nanjing, China). All animal experiments
were carried out in compliance with the Animal Management Rules (Ministry of Health,
People’s Republic of China) and the Guidance for Care and Use of Laboratory Animals
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Figure S 2: (A) Representative photographs of HSH hydrogels 7 days after subcutaneous
injection in C57BL6 mice showing negligible volume decrease over this time. (B) Intravital
fluorescence imaging of mice treated with a buffer solution of ICG. (C) Changes in tumor
volume in mice treated with HSH, free Dox or free γ-Fe2O3 nanoparticles. Magnetic field
was applied for 2 min on day 2, 4, 6, 8, 10 and 12 in all treatment groups.
(China Pharmaceutical University). As shown in Figure S2A, HSH hydrogels reformed
immediately following local injection and remained intact for 7 days.
In order to study the in vivo cargo release profile, six to eight-week-old athymic nu/nu
(BALB/c) mice were 100 µL of ICG-loaded HSH ([ICG] = 100 µM) was injected sub-
cutaneously into the rear right flank of each mouse bearing xenograft tumor (Figure S2B).
Treatment groups were injected with ICG-loaded HSH and subjected to ~B for different length
of time (0, 2, 4, 6 and 8 min, n=3). Control groups were injected with ICG-loaded HSH
and treated in the absence of ~B, or injected with a buffer solution of ICG ([ICG]=100 µM,
100 µL, n=2).
Changes in tumor volume in mice treated with HSH, free Dox, or free γ-Fe2O3 nanopar-
ticles ([Dox] = 1 mg/mL, [γ-Fe2O3] = 0.1 %, 100 µL) are demonstrated in Figure S2C.
Only HSH which contains Dox and superparamagnetic nanoparticles in a polymeric matrix
through non-covalent interactions shows effective tumor suppression. Pathological inspec-
tion of important visceral organs is shown in Figure S3, where no lymphocyte infiltration,
necrosis, fibrosis or other abnormal phenomena were observed in the HSH-treated groups.
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Figure S 3: H&E staining of major organ sections collected from mice treated with PBS
buffer, Dox-loaded HSH in the absence of ~B, free Dox and Dox-loaded HSH in the presence
of ~B. Scale bar, 20 µm.
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